Youtube video coming soon

Symbol CSE: ISOL  OTC: ISOLF FWB: LB6A 

Company Overview

Isodiol International Inc.  is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products.

Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99%+ pure, bioactive pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products.

Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue international expansion into Latin America, Asia and Europe.

view more: https://isodiol.com/

Isodiol International Inc. Reports Fiscal Year 2019 Audited Financial Results

#ISOL #ISOLF VANCOUVER, British Columbia, Aug. 16, 2019 (GLOBE NEWSWIRE) — Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), announces that it has filed its audited consolidated financial statements and MD&A for the year ended March 31, 2019. Highlights of Fiscal Year 2019 include: Total revenues of $22,248,171, an increase of 16.26% over the prior year,

Isodiol International Inc. Announces Termination of Agreements With Carlsbad Naturals LLC

VANCOUVER, British Columbia, July 18, 2019 (GLOBE NEWSWIRE) — Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”),  announces that the asset purchase agreement among the Company, Iso International LLC and Carlsbad Naturals LLC, a New Mexico limited liability company (“Carlsbad New Mexico”), and the asset purchase agreement among the Company, Iso International LLC and Carlsbad Naturals

Isodiol International Inc. Announces Notice of Annual General Meeting and Issues Updates on Mexico Operations and Restructuring Efforts

Isodiol looks forward to the issuance of new regulations and licenses in Mexico authorizing the distribution and sale of CBD-based medical products and Consumer Packaged Goods (CPG) VANCOUVER, British Columbia, May 16, 2019 (GLOBE NEWSWIRE) — Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), announces that it will hold its annual general meeting of the Company’s shareholders

Isodiol International Inc. Continues Its FY2020 Trade Show Program at the ECRM Pet EPPs Trade Conference Through May 01, 2019 in Itasca, Illinois

“our All-Natural CBD-Supplement line, Pawceuticals, presents numerous opportunities” #ISOL #ISOLF Isodiol is furthering its position in the Pet Industry and is showcasing its All-Natural CBD Supplement Line, Pawceuticals at Pet EPPS VANCOUVER, British Columbia, May 01, 2019 (GLOBE NEWSWIRE) — Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) is exhibiting at The Efficient Collaborative Retail Marketing Company (“ECRM”)